(BVI) Bureau Veritas - Overview
Sector: Industrials | Industry: Consulting Services | Exchange: PA (France) | Market Cap: 11.946m EUR | Total Return: -8.5% in 12m
Avg Turnover: 20.7M
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Bureau Veritas SA (BVI) is a global provider of laboratory testing, inspection, and certification (TIC) services. Founded in 1828 and headquartered in France, the company operates across six primary segments: Marine & Offshore, Agri-Food & Commodities, Industry, Buildings & Infrastructure, Certification, and Consumer Products. Its core business model involves auditing and certifying assets, products, and management systems against regulatory and voluntary standards for clients in approximately 140 countries.
The TIC sector functions as a critical intermediary in global trade, driven by increasing regulatory complexity and ESG compliance requirements. Bureau Veritas benefits from a diversified revenue stream, serving industries ranging from aerospace and nuclear power to retail and financial services. The company’s extensive network of offices and laboratories provides a high barrier to entry due to the specialized technical expertise and global accreditation required to issue compliance reports. Investors may find it useful to review ValueRay for further data on the companys valuation metrics.
- Global sustainability regulations accelerate demand for green building and energy transition certification
- Rising infrastructure spending in emerging markets boosts technical inspection and audit revenue
- Fluctuating commodity prices impact testing volumes within the Agri-Food and Minerals segments
- Decarbonization requirements in the shipping industry drive Marine and Offshore service growth
| Net Income: 1.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 7.30 > 1.0 |
| NWC/Revenue: 8.99% < 20% (prev 12.49%; Δ -3.50% < -1%) |
| CFO/TA 0.28 > 3% & CFO 1.96b > Net Income 1.16b |
| Net Debt (2.53b) to EBITDA (2.22b): 1.14 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (445.7m) vs 12m ago -2.73% < -2% |
| Gross Margin: 43.06% > 18% (prev 0.29%; Δ 4.28k% > 0.5%) |
| Asset Turnover: 186.8% > 50% (prev 151.6%; Δ 35.23% > 0%) |
| Interest Coverage Ratio: 8.22 > 6 (EBITDA TTM 2.22b / Interest Expense TTM 199.1m) |
| A: 0.16 (Total Current Assets 3.31b - Total Current Liabilities 2.16b) / Total Assets 7.06b |
| B: 0.23 (Retained Earnings 1.66b / Total Assets 7.06b) |
| C: 0.24 (EBIT TTM 1.64b / Avg Total Assets 6.85b) |
| D: 0.32 (Book Value of Equity 1.71b / Total Liabilities 5.31b) |
| Altman-Z'' = 3.78 = AA |
| DSRI: 0.78 (Receivables 1.94b/1.94b, Revenue 12.8b/10.1b) |
| GMI: 0.68 (GM 43.06% / 29.18%) |
| AQI: 1.01 (AQ_t 0.42 / AQ_t-1 0.41) |
| SGI: 1.27 (Revenue 12.8b / 10.1b) |
| TATA: -0.11 (NI 1.16b - CFO 1.96b) / TA 7.06b) |
| Beneish M = -3.41 (Cap -4..+1) = AA |
As of May 29, 2026, the stock is trading at EUR 25.75 with a total of 710,483 shares traded.
Over the past week, the price has changed by -1.42%,
over one month by +4.13%,
over three months by -9.39% and
over the past year by -8.54%.
Bureau Veritas has no consensus analysts rating.
P/E Trailing = 20.5344
P/E Forward = 17.8253
P/S = 1.788
P/B = 6.9818
P/EG = 2.8733
Revenue TTM = 12.8b EUR
EBIT TTM = 1.64b EUR
EBITDA TTM = 2.22b EUR
Long Term Debt = 2.39b EUR (from longTermDebt, last quarter)
Short Term Debt = 347.9m EUR (from shortTermDebt, last quarter)
Debt = 3.90b EUR (from shortLongTermDebtTotal, last quarter) + Leases 465.6m
Net Debt = 2.53b EUR (calculated: Debt 3.90b - CCE 1.37b)
Enterprise Value = 14.5b EUR (11.9b + Debt 3.90b - CCE 1.37b)
Interest Coverage Ratio = 8.22 (Ebit TTM 1.64b / Interest Expense TTM 199.1m)
EV/FCF = 8.67x (Enterprise Value 14.5b / FCF TTM 1.67b)
FCF Yield = 11.53% (FCF TTM 1.67b / Enterprise Value 14.5b)
FCF Margin = 13.04% (FCF TTM 1.67b / Revenue TTM 12.8b)
Net Margin = 9.04% (Net Income TTM 1.16b / Revenue TTM 12.8b)
Gross Margin = 43.06% ((Revenue TTM 12.8b - Cost of Revenue TTM 7.29b) / Revenue TTM)
Gross Margin QoQ = 5.32% (prev 23.27%)
Tobins Q-Ratio = 2.05 (Enterprise Value 14.5b / Total Assets 7.06b)
Interest Expense / Debt = 5.11% (Interest Expense 199.1m / Debt 3.90b)
Taxrate = 35.08% (146.9m / 418.7m)
NOPAT = 1.06b (EBIT 1.64b * (1 - 35.08%))
Current Ratio = 1.53 (Total Current Assets 3.31b / Total Current Liabilities 2.16b)
Debt / Equity = 2.28 (Debt 3.90b / totalStockholderEquity, last quarter 1.71b)
Debt / EBITDA = 1.14 (Net Debt 2.53b / EBITDA 2.22b)
Debt / FCF = 1.52 (Net Debt 2.53b / FCF TTM 1.67b)
Total Stockholder Equity = 1.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.89% (Net Income 1.16b / Total Assets 7.06b)
RoE = 68.54% (Net Income TTM 1.16b / Total Stockholder Equity 1.69b)
RoCE = 40.11% (EBIT 1.64b / Capital Employed (Equity 1.69b + L.T.Debt 2.39b))
RoIC = 20.77% (NOPAT 1.06b / Invested Capital 5.11b)
WACC = 6.40% (E(11.9b)/V(15.8b) * Re(7.41%) + D(3.90b)/V(15.8b) * Rd(5.11%) * (1-Tc(0.35)))
Discount Rate = 7.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -55.56 | Cagr: -1.10%
[DCF] Terminal Value 77.97% ; FCFF base≈1.44b ; Y1≈1.65b ; Y5≈2.42b
[DCF] Fair Price = 76.38 (EV 36.5b - Net Debt 2.53b = Equity 33.9b / Shares 444.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 79.51 | Revenue CAGR: 15.52% | SUE: 0.00 | # QB: 0
EPS current Year (2026-12-31): EPS=1.53 | Chg30d=-1.67% | Revisions=-29% | GrowthEPS=+8.1% | GrowthRev=+4.0%
EPS next Year (2027-12-31): EPS=1.66 | Chg30d=-2.05% | Revisions=-14% | GrowthEPS=+8.4% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: -29%